Skip to content
2000
Volume 11, Issue 5
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

The incidence of gastric cancer is third most prevalent among all malignant tumors in China. The conventional therapies for advanced gastric cancer are futile. Targeted gene therapy has become a promising alternative approach. Mesenchymal stem cells (MSCs) can be used as potential cellular vehicles for cancer therapy in vivo. This review will summarize the published data about the application of MSC-based targeted therapy for gastric cancer, and discuss some of the challenges associated with this method.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cscr/10.2174/1574888X10666151026113818
2016-07-01
2025-09-04

  • From This Site

    /content/journals/cscr/10.2174/1574888X10666151026113818
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/1574888X10666151026113818
Loading

  • Article Type:     Research Article
Keyword(s): Challenges; conventional therapies; gastric cancer; mesenchymal stem cells; targeted gene therapy; vehicle

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test